*Result*: Total neoadjuvant therapy for rectal cancer in the CAO/ARO/AIO-12 randomized phase 2 trial: early surrogate endpoints revisited
*Author/editor-in-chief*:
Diefenhardt, Markus (Verfasser) ; Schlenska-Lange, Anke (Verfasser) ; Kuhnt, Thomas (Verfasser) ; Kirste, Simon (Verfasser) ; Piso, Pompiliu Ioan (Verfasser) ; Bechstein, Wolf Otto (Verfasser) ; Hildebrandt, Guido (Verfasser); Ghadimi, Michael (Verfasser) ; Hofheinz, Ralf-Dieter (Verfasser) ; Rödel, Claus (Verfasser) ; Fokas, Emmanouil (Verfasser) ; German Rectal Cancer Study Group (Forscher)
*Publication*:
Freiburg : Universität, 2022
*Physical description scale*:
1 Online-Ressource
*Format*:
*Language*:
*eng*
*Notes*:
Cancers. - 14, 15 (2022) , 3658, ISSN: 2072-6694
*DOI*:
10.3390/cancers14153658